COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2021-03-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | http://www.actamedindones.org/index.php/ijim/article/view/1766 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839630209361379328 |
---|---|
author | Siti Setiati Jessica Marsigit |
author_facet | Siti Setiati Jessica Marsigit |
author_sort | Siti Setiati |
collection | DOAJ |
description |
It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not only in Indonesia, but the number of new cases along with the mortality rate in other countries, such as Malaysia, Japan, United States, and Europe region also increased dramatically.
COVID-19 vaccines are being investigated and the world hopes that vaccines will be the answer to tackle this pandemic. Is it really so? Immunization is an effort to induce immunity in individuals to prevent a disease or the complication related to the diseases that may be catastrophic. Immunization can be divided into passive, which is by giving certain type of antibody and active, which means that either we get the disease, or we get the antigen injected into our body.
Having prior vaccination or past COVID-19 does not mean that someone is totally immune to COVID-19 as a recent study suggested that the antibody related to COVID-19 past infection is significantly decreasing after 3 months post-infection. Compliance to implementation of health protocol remained the most crucial strategy during this pandemic.
|
format | Article |
id | doaj-art-d92f88f2d8d24c47b9f15e689ab7fbfb |
institution | Matheson Library |
issn | 0125-9326 2338-2732 |
language | English |
publishDate | 2021-03-01 |
publisher | Interna Publishing |
record_format | Article |
series | Acta Medica Indonesiana |
spelling | doaj-art-d92f88f2d8d24c47b9f15e689ab7fbfb2025-07-14T07:01:41ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322021-03-01531COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?Siti Setiati0Jessica Marsigit11. Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia. 2. Clinical Epidemiology and Evidence-Based Medicine, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not only in Indonesia, but the number of new cases along with the mortality rate in other countries, such as Malaysia, Japan, United States, and Europe region also increased dramatically. COVID-19 vaccines are being investigated and the world hopes that vaccines will be the answer to tackle this pandemic. Is it really so? Immunization is an effort to induce immunity in individuals to prevent a disease or the complication related to the diseases that may be catastrophic. Immunization can be divided into passive, which is by giving certain type of antibody and active, which means that either we get the disease, or we get the antigen injected into our body. Having prior vaccination or past COVID-19 does not mean that someone is totally immune to COVID-19 as a recent study suggested that the antibody related to COVID-19 past infection is significantly decreasing after 3 months post-infection. Compliance to implementation of health protocol remained the most crucial strategy during this pandemic. http://www.actamedindones.org/index.php/ijim/article/view/1766COVID-19vaccineelderlyCOVID-19 vaccine |
spellingShingle | Siti Setiati Jessica Marsigit COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive? Acta Medica Indonesiana COVID-19 vaccine elderly COVID-19 vaccine |
title | COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive? |
title_full | COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive? |
title_fullStr | COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive? |
title_full_unstemmed | COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive? |
title_short | COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive? |
title_sort | covid 19 vaccine for elderly should we be reactive or proactive |
topic | COVID-19 vaccine elderly COVID-19 vaccine |
url | http://www.actamedindones.org/index.php/ijim/article/view/1766 |
work_keys_str_mv | AT sitisetiati covid19vaccineforelderlyshouldwebereactiveorproactive AT jessicamarsigit covid19vaccineforelderlyshouldwebereactiveorproactive |